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This study was designed to determine the etiology of status epilepticus (SE) and 
its relation to mortality.
Materials and Methods
This descriptive study was carried out based on the medical records of 40 
patients with diagnosis of SE discharged from pediatric hospital of Bandar Abbas 
between March 2002 and March 2004. Multivariant analysis was pereformed 
to determine the prevalence of the disorder and the relation between SE and 
other factors such as gender, age, response to treatment, and mortality. We 
classified the etiology according to international league against epilepsy (ILAE) 
classification and also uses another classification regarding underlying causes 
such as fever (non-CNS infection), central nervous system infection, hypoxia, 
and metabolic causes.
Results 
Status epilepticus was responsible for 0.3% of all hospital admissions during 
the study period. Based on the ILAE classification, frequencies for acute 
symptomatic, febrile, progressive encephalopathic, remote, and cryptogenic SE 
were 42.5%, 32.5%, 10%, 7.5%, and 7.5%, respectively.
The most common underlying causes resulting in SE were fever (45%), metabolic 
disorders (15%), CNS infection (12.5%), chronic neurologic diseases (7.5%), 
idiopathic (7.5%), hypoxia (5%), drug withdrawal (2.5%), CNS hemorrhage 
(2.5%), neurodegenerative disease (2.5%), brain abscess (2.5%), and post DPT
(Diphteria,Pertusis,Tetanus) vaccination (2.5%). Mortality rate was 25% (80% 
in the patients younger than 5 years and 40% in those aged less than 1 year). 
Occurrence of SE and its mortality was found to be related to age (p< 0.05).
Conclusion
For SE, if seizures continue for more than 5 minutes, treatment must be 
initiated. The outcome is determined by etiology, age, seizure duration and 
management; however, all we can do is enhance the management and increase 
its effectiveness. 
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Introduction 
Status epilepticus (SE) is usually a manifestation of an acute precipitating event that 
affects the central nervous system (CNS) or an exacerbation of symptomatic epilepsy 
(1). It is a medical and neurological emergency, accompanied with significant 
mortality and morbidity (1,2). Status epilepticus is internationally classified as a 
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seizure lasting for more than 5 minutes or two or more 
separate seizures having a period of incomplete recovery 
of consciousness (2-4).
Based on the classification of the International League 
Against Epilepsy (ILAE), etiologies include acute 
symptomatic SE, cryptogenic SE, remote symptomatic 
SE, febrile SE, and progressive encephalopathy (5). The 
other classification of etiologies used by some authors 
was based on underlying diseases such as fever (non-
CNS infection), CNS infection, idiopathic, metabolic, 
chronic neurologic disease, and tumors (1, 3).
Etiologies of SE, used in children, differ clearly from 
those used for adults (1). Age has been documented as a 
risk factor for SE (1, 4). Status epilepticus has a bimodal 
distribution with the highest value during the first years 
and the 6th decade of life and after that (2). More than 
80% of children, under the age of 2 years, have SE of a 
febrile or acute symptomatic cause, whereas, cryptogenic 
or remote symptomatic causes were more common in 
older children (1); in contrast, sub therapeutic levels of 
antiepileptic drugs, remote causes and cerebrovascular 
accidents represent the three most common etiologies of 
SE reported in adults (2). 
Status epilepticus is usually underestimated and diagnosis 
of some types of the condition is not easy. Treatment 
in diagnosed SE is often initiated with delay or is not 
enough (1). The most dramatic decrease in morbidity and 
mortality has occurred in pediatric populations, probably 
due to more rapid interventions and improved treatment 
modalities (4). Mortality of SE is reported to range from 
3% to 6% among children which is lower than that in 
adults (1, 4). Prompt diagnosis and management has been 
associated with improved outcomes (1, 4, 5). Since the 
etiology of SE in our area has not been clearly defined, 
this study was designed to determine the etiology of 
status epilepticus and its relation with mortality.
Materials And Methods
In this descriptive study, the medical records of all 40 
hospitalized SE patients evaluated and managed were 
collected during a two year period (March 2002 to March 
2004) and studied.
The data gathered from medical records included 
information on underlying causes of SE, etiology, age, 
gender, duration of hospitalization, previous seizure, 
previous SE, family history, type of seizure, duration 
of SE, response to treatment, outcome of SE as well as 
paraclinic test results such as ABG, CBC, LP(lumbar 
puncture), blood sugar, electrolytes, blood culture, BUN, 
and chest X-ray. 
After resuscitation of the patients, checking of vital signs, 
insertion of IV line, and blood sampling for laboratory 
tests, they were treated according to the following 
protocol: 
1. A bolus of 25% glucose was given during the first 5 
minutes and afterwards diazepam was infused with the 
dose of 0.3 mg/kg. 
2. If seizure persisted, a repeat dose of 0.3 mg/kg 
diazepam was infused in 10 minutes of seizure onset. 
3. If seizure persisted, in 15 minutes of onset, a loading 
dose of phenytoin (10mg/kg) was started and if the 
seizure was controlled, phenytoin was administered with 
a maintenance dose.
4. If not, another dose of phenytoin (10mg/kg) was given 
within 30 minutes of seizure onset.  
5. If seizure persisted, after 45 minutes of onset, an IV 
infusion of phenobarbital (20 mg/kg) was administered. 
If the seizures were controlled during each step, a 
maintenance dose of phenytoin (5mg/kg/day) was 
started.
6. If not, after 60 minutes of seizure onset, a midazolam 
drip was administered with the initial bolus dose of 0.15 
mg/kg followed by 1 to 5 micrograms/kg/min infusion. 
The etiology of SE was determined according to the two 
types of classifications (ILAE and underlying disease). 
Data was analyzed using Epi Info software, p< 0.05 
being considered statistically significant.
Results
Of all the patients hospitalized, 0.3% were diagnosed 
as SE cases, of which 62.5% were male; mean age of 
the patients was 26.6 months and mean duration of 
hospitalization was 6.5 days.
The most common etiologies based on ILAE 
classification were acute symptomatic (47.5%), febrile 
(32.5%), progressive encephalopathic (10%), remote 
symptomatic (5%), and cryptogenic SE (5%) (Figure 1). 
The most common underlying causes were fever (45%), 
metaboloic disorders (12.5%), and CNS infection 
(12.5%). Other etiologic causes classified were, chronic 
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neurologic disease, idiopathic, hypoxia, brain abscess, 
neurodegenerative diseases, intracranial hemorrhage, 
drug withdrawal, and post DPT-vaccination (Figure 2).
In 77.5% of the patients, seizure lasted more than one 
hour. Four patients (10%) had previous history of 
SE. Mortality rate was 25% (10 cases, 4 males and 6 
females). The most common etiologies leading to death 
were acute symptomatic SE (42.1%) (Table 1). Eighty 
percent of mortalities occurred in those aged under 5 
years, of which, 40% were younger than 1 year (Table 
2). There was also a significant relationship (p< 0.05) 
between etiology and response to the treatment (Table 
3). Statistical analysis of the results shows that etiology 
based on ILAE classification and mortality, etiology 
and response to treatment were significantly related (p< 
0.05) .
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Table 1: Relation between etiology and mortality among patients
Etiology Relieved Death
Acute Symptomatic SE 57.9% 42.1%
Remote Symptomatic SE 100% 0%
Cryptogenic SE 100% 0%
Febrile SE 92.3% 7.7%
Progressive Encephalopathic 75% 25%
P value is less than 0.05.
Table 2: Relation between age and mortality in patients
DeathRelievedPercent of the SE patientsAge




P value is less than 0.05.
Table 3: Relation between etiology and response to treatment among patients
Etiology
Response to first line 
treatment
NO response to first 
line treatment
Refractory to all 
drugs
Acute Symptomatic SE 78.9% 21.1% 5.2%
Remote Symptomatic SE 100% 0% 0%
Cryptogenic SE 100% 0% 0%
Febrile SE 84.6% 15.4% 0%
Progressive Encephalopathic 25% 75% 25%
P value is less than 0.05.
Discussion
Acute symptomatic SE was the most common type in our study (42.5%). Acute symptomatic, cryptogenic, and febrile SE 
were the most common causes before (35%, 30%, and 25%, respectively). In another study, symptomatic SE, idiopathic, 
and progressive SE (60%, 11%, and 11%) were more common (7). In our study, the most common underlying diseases 
leading to SE, were fever (45%), metabolic disorders (12.5%), and CNS infection (12.5%); however in the study of 
DeLorenzo, they were infection (non-CNS) and idiopathic (36% and 24% to 39%) (3).
In our study, SE occurred in 62.5% of the cases in males which is in accordance with the results of Phillips and Shanahan 
(61%) and Ibrahim and colleagues (66.7%) (8,9). Previous history of seizure was 37.5% in our study, similar to the 
finding of 35% in the Kwong and associates study (7). Ten percent of our patients had more than one attack of SE which 
was reported to be 10.8% and 12% in previous studies (7,9).
Mean duration of hospitalization was 6.5 days in our study, as compared to 5.5 days in the study conducted by Ibrahim, 
whose mortality rate was similar to ours of 25% (9) and in contrast to the study of Kwong (11%) (6), Coeytaux (7.6%), 
and Philips (6%) (8); the high mortality rate in our study may be due to the fact that our study was performed in a referral 
pediatric hospital.
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According to our results, SE is age dependent. The most 
common etiologies in childhood are acute symptomatic 
(47.5%) and febrile SE, similar to the results of Phillip’s 
study performed on 193 patients aged from 1month to 14 
years. The most common etiologies in children younger 
than one year were acute causes [bacterial meningitis 
(27%), electrolyte disorders (30%), idiopathic (23%), 
and fever (19%)]. In children aged below 3 years, acute 
causes were responsible for 47% of the cases (8). In 
a study conducted by Coeytaux, 108 cases had acute 
symptomatic SE (10), whereas in the Kwong study, 
the most common etologies were anti-convalsant drug 
withdrawal, metabolic derangement, and cerebrovascular 
diseases (7).
These studies show that SE etiology is age dependent and 
in the lower age ranges, acute symptomatic (especially 
CNS infection) and febrile SE are the two common 
etiologies (1, 4, 8, 10). In our study, 10% of the patients 
had more than one episode of SE which is similar to the 
results of a prospective study performed by Berg (9.5%) 
(11).
Conclusion
Identifying the underlying etiology plays an important 
role in the management of patients with SE and in 
reducing mortality. Our study shows a high mortality 
rate in young children especially those aged less than 
one year. Physicians must be aware of and emphasize 
the importance of SE in this age group.
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